Clinical spectrum of X-linked hyper-IgM syndrome

被引:471
|
作者
Levy, J
EspanolBoren, T
Thomas, C
Fischer, A
Tovo, P
Bordigoni, P
Resnick, I
Fasth, A
Baer, M
Gomez, L
Sanders, EAM
Tabone, MD
Plantaz, D
Etzioni, A
Monafo, V
Abinun, M
Hammarstrom, L
Abrahamsen, T
Jones, A
Finn, A
Klemola, T
DeVries, E
Sanal, O
Peitsch, MC
Notarangelo, LD
机构
[1] SOROKA HOSP, BEER SHEVA, ISRAEL
[2] HOSP GEN VALLE HEBRON, BARCELONA, SPAIN
[3] HOP NECKER ENFANTS MALAD, PARIS, FRANCE
[4] UNIV TURIN, TURIN, ITALY
[5] UNIV NANCY, NANCY, FRANCE
[6] INST PEDIT HEMATOL, MOSCOW, RUSSIA
[7] UNIV GOTHENBURG, GOTHENBURG, SWEDEN
[8] UNIV TAMPERE, FIN-33101 TAMPERE, FINLAND
[9] INST IMMUNOL, MOSCOW, RUSSIA
[10] WILHELMINA GASTHUIS, UTRECHT, NETHERLANDS
[11] HOP TROUSSEAU, F-75571 PARIS, FRANCE
[12] UNIV GRENOBLE, GRENOBLE, FRANCE
[13] RAMBAM MED CTR, HAIFA, ISRAEL
[14] UNIV PAVIA, I-27100 PAVIA, ITALY
[15] NEWCASTLE GEN HOSP, NEWCASTLE UPON TYNE NE4 6BE, TYNE & WEAR, ENGLAND
[16] KAROLINSKA INST, HUDDINGE, SWEDEN
[17] UNIV OSLO, NATL HOSP, OSLO, NORWAY
[18] INST CHILD HLTH, LONDON, ENGLAND
[19] SHEFFIELD CHILDRENS HOSP, SHEFFIELD S10 2TH, S YORKSHIRE, ENGLAND
[20] UNIV HELSINKI, CHILDRENS HOSP, HELSINKI, FINLAND
[21] UNIV LEIDEN HOSP, NL-2300 RC LEIDEN, NETHERLANDS
[22] UNIV HACETTEPE, CHILDRENS HOSP, TR-06100 ANKARA, TURKEY
[23] GLAXO WELLCOME INC, GENEVA, SWITZERLAND
[24] UNIV BRESCIA, BRESCIA, ITALY
来源
JOURNAL OF PEDIATRICS | 1997年 / 131卷 / 01期
关键词
D O I
10.1016/S0022-3476(97)70123-9
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We report the clinical and immunologic features and outcome in 56 patients with X-linked hyper-IgM syndrome, a disorder caused by mutations in the CD40 ligand gene. Upper and lower respiratory tract infections (the latter frequently caused by Pneumocystis carinii), chronic diarrhea, and liver involvement (both often associated with Cryptosporidium infection) were common. Many patients had chronic neutropenia associated with oral and rectal ulcers. The marked prevalence of infections caused by intracellular pathogens suggests some degree of impairment of cell-mediated immunity. Although lymphocyte counts and in vitro proliferation to mitogens were normal, a defective in vitro proliferative response to antigens was observed in some patients, and additional defects of cell-mediated immunity may be presumed on the basis of current knowledge of CD40-ligand function. All patients received regular infusions of immunoglobulins. Four patients underwent liver transplantation, because of sclerosing cholangitis, which relapsed in three. Three patients underwent bone marrow transplantation. Thirteen patients (23%) died of infection and/or liver disease. X-linked hyper-IgM syndrome, once considered a clinical variant of hypogammaglobulinemia, is a severe immunodeficiency with significant cellular involvement and a high mortality rate.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [1] Clinical and genetic analysis of patients with X-linked hyper-IgM syndrome
    Vargas-Hernandez, A.
    Berron-Ruiz, L.
    Staines-Boone, T.
    Zarate-Hernandez, MdC
    Cordova-Calderon, W. O.
    Espinosa-Rosales, F. J.
    Santos-Argumedo, L.
    CLINICAL GENETICS, 2013, 83 (06) : 585 - 587
  • [2] Spectrum of the X-linked hyper IgM syndrome
    Dent, P
    JOURNAL OF PEDIATRICS, 1998, 132 (03): : 561 - 561
  • [3] The X-linked hyper-IgM syndrome - Clinical and immunologic features of 79 patients
    Winkelstein, JA
    Marino, MC
    Ochs, H
    Fuleihan, R
    Scholl, PR
    Geha, R
    Stiehm, ER
    Conley, ME
    MEDICINE, 2003, 82 (06) : 373 - 384
  • [4] NEUROENDOCRINE CARCINOMA ASSOCIATED WITH X-LINKED HYPER-IGM SYNDROME
    Erdos, Melinda
    Garami, Miklos
    Rakoczi, Eva
    Zalatnai, Attila
    Steinbach, Daniel
    Baumann, Ulrich
    Kropshofer, Gabrielle
    Toth, Beata
    Marodi, Laszlo
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 716 - 716
  • [5] Clinical and Molecular Characterization of X-linked Hyper-IgM Syndrome Patients in China
    An, Y.
    Xiao, J.
    Jiang, L.
    Yang, X.
    Yu, J.
    Zhao, X.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 72 (01) : 50 - 56
  • [6] Gene therapy for X-linked hyper-IgM syndrome.
    Zoltick, PW
    Genin, A
    Flake, AW
    Cron, RQ
    CLINICAL IMMUNOLOGY, 2005, 116 (03) : 304 - 304
  • [7] PRENATAL-DIAGNOSIS OF X-LINKED HYPER-IGM SYNDROME
    DISANTO, JP
    MARKIEWICZ, S
    GAUCHAT, JF
    BONNEFOY, JY
    FISCHER, A
    DESAINTBASILE, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14): : 969 - 973
  • [8] X-linked immunodeficiency with hyper-IgM (XHIM)
    Notarangelo, LD
    Hayward, AR
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (03): : 399 - 405
  • [9] Necrotizing toxoplasmic encephalitis in a child with the X-linked hyper-IgM syndrome
    I. Tsuge
    H. Matsuoka
    A. Nakagawa
    Y. Kamachi
    K. Aso
    T. Negoro
    M. Ito
    S. Torii
    K. Watanabe
    European Journal of Pediatrics, 1998, 157 : 735 - 737
  • [10] Targeted Gene Therapy in the Treatment of X-Linked Hyper-IGM Syndrome
    Kuo, C. Y.
    Hoban, M. D.
    Joglekar, A. V.
    Kohn, D. B.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S182 - S182